APA

Badano J. L., Kim J. C., Hoskins B. E., Lewis R. A., Ansley S. J., Cutler D. J., Castellan C., Beales P. L., Leroux M. R. & Katsanis N. (20031003). Heterozygous mutations in BBS1, BBS2 and BBS6 have a potential epistatic effect on Bardet-Biedl patients with two mutations at a second BBS locus. : Human molecular genetics.

Chicago

Badano Jose L, Kim Jun Chul, Hoskins Bethan E, Lewis Richard Alan, Ansley Stephen J, Cutler David J, Castellan Claudio, Beales Philip L, Leroux Michel R and Katsanis Nicholas. 20031003. Heterozygous mutations in BBS1, BBS2 and BBS6 have a potential epistatic effect on Bardet-Biedl patients with two mutations at a second BBS locus. : Human molecular genetics.

Harvard

Badano J. L., Kim J. C., Hoskins B. E., Lewis R. A., Ansley S. J., Cutler D. J., Castellan C., Beales P. L., Leroux M. R. and Katsanis N. (20031003). Heterozygous mutations in BBS1, BBS2 and BBS6 have a potential epistatic effect on Bardet-Biedl patients with two mutations at a second BBS locus. : Human molecular genetics.

MLA

Badano Jose L, Kim Jun Chul, Hoskins Bethan E, Lewis Richard Alan, Ansley Stephen J, Cutler David J, Castellan Claudio, Beales Philip L, Leroux Michel R and Katsanis Nicholas. Heterozygous mutations in BBS1, BBS2 and BBS6 have a potential epistatic effect on Bardet-Biedl patients with two mutations at a second BBS locus. : Human molecular genetics. 20031003.